Zantac, or ranitidine, has been found to be contaminated with NDMA—a known carcinogen. Because of this link, and because of further findings that ranitidine develops NDMA contamination over time in storage and in the body, the Food and Drug Administration (FDA) called for all drugs containing ranitidine under the brand name Zantac to be withdrawn from the market. This defective medication’s cancer link has also led to thousands of lawsuits against the manufacturers of Zantac for patients’ cancer-related damages.
However, despite the recall and the lawsuits, no definitive link between ranitidine and cancer formation has been found. In addition, it’s unclear what your risk of developing cancer might be if you’ve taken Zantac in the past.
This doesn’t mean you’re out of luck if you develop cancer after taking Zantac. If you or a loved one has bladder cancer, colon cancer, prostate cancer, kidney cancer, liver cancer, stomach cancer, breast cancer, or another type of cancer, and have been on a regimen of Zantac, you could be entitled to financial compensation. Call our lawyers who specialize in mass tort cases at Gordon McKernan Injury Attorneys for a free legal consultation.
GET HELP NOW!